In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans

M. Javad Najafzadeh, Deanna A. Sutton, M. Saradeghi Keisari, Hossein Zarrinfar, G. Sybren De Hoog, Anuradha Chowdhary, Jacques F. Meis

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Aureobasidium pullulans is an unusual agent of phaeohyphomycosis. The in vitro activities of antifungals against 104 isolates of Aureobasidium pullulans var. pullulans and A. pullulans var. melanigenum revealed low MIC90s of amphotericin B, posaconazole, and itraconazole. However, they were resistant to fluconazole (≥64 μg/ml) and had high MICs of voriconazole, isavuconazole, caspofungin, and micafungin.

Original languageEnglish (US)
Pages (from-to)5629-5631
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume58
Issue number9
DOIs
StatePublished - Sep 1 2014

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans'. Together they form a unique fingerprint.

Cite this